Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288045131> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4288045131 endingPage "16" @default.
- W4288045131 startingPage "13" @default.
- W4288045131 abstract "Comorbid borderline personality disorder and major depressive disorder is common and often not adequately responsive to standard antidepressant therapies. Ketamine is a potentially life-saving option.153 adult patients with MDD were assessed with the Personality Assessment Inventory (PAI) Borderline Subscale. Data was normally distributed with a mean + SD of 38.95 + 11.54. Patients >1 SD above the mean were assigned to the MDD + BF group. All others were assigned to the MDD-BF group. Patients were administered IV ketamine 0.5 mg/kg of ketamine over 40 min. Mood was assessed using the Beck Depression Inventory-II at baseline, 3 and 24 h post-ketamine. Scores between the MDD + BF and MDD-BF group at each time point were compared using t-test or analysis of covariance (ANCOVA) model. The primary outcome was response at 24 h.The LS mean change in BDI at 24 h was -23.8 (15.3) for MDD + BF and -21.0 (13.5) for MDD-BF (F [1151] = 0.043, p = 0.51). The LS mean change in BDI at 3 h was -21.3 (13.2) for MDD + BF and -19.6 (13.2) for MDD-BF (F[1151] = 0.045, p = 0.83). The LS mean change in BDI at 14 days was -23.2 (15.3) for MDD + BF and -15.3 (15.2) for MDD-BF (F[1130] = 4.24, p = 0.04).People in the MDD + BF group were not necessarily diagnosable with borderline personality disorder.These data indicate that IV ketamine is effective in MDD patients with and without elevated borderline features. This can provide clinicians some reassurance about using ketamine in this population." @default.
- W4288045131 created "2022-07-27" @default.
- W4288045131 creator A5032475668 @default.
- W4288045131 creator A5048622877 @default.
- W4288045131 creator A5087160785 @default.
- W4288045131 date "2022-10-01" @default.
- W4288045131 modified "2023-10-16" @default.
- W4288045131 title "The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder" @default.
- W4288045131 cites W1865092458 @default.
- W4288045131 cites W1976396510 @default.
- W4288045131 cites W1984140685 @default.
- W4288045131 cites W2003835284 @default.
- W4288045131 cites W2009769854 @default.
- W4288045131 cites W2023081218 @default.
- W4288045131 cites W2023687307 @default.
- W4288045131 cites W2054437388 @default.
- W4288045131 cites W2064430235 @default.
- W4288045131 cites W2084013562 @default.
- W4288045131 cites W2097857685 @default.
- W4288045131 cites W2103255996 @default.
- W4288045131 cites W2109334244 @default.
- W4288045131 cites W2128918664 @default.
- W4288045131 cites W2161766952 @default.
- W4288045131 cites W2762798648 @default.
- W4288045131 cites W2771797851 @default.
- W4288045131 cites W2779386549 @default.
- W4288045131 cites W2796940952 @default.
- W4288045131 cites W3107192515 @default.
- W4288045131 doi "https://doi.org/10.1016/j.jad.2022.07.054" @default.
- W4288045131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35905793" @default.
- W4288045131 hasPublicationYear "2022" @default.
- W4288045131 type Work @default.
- W4288045131 citedByCount "2" @default.
- W4288045131 countsByYear W42880451312023 @default.
- W4288045131 crossrefType "journal-article" @default.
- W4288045131 hasAuthorship W4288045131A5032475668 @default.
- W4288045131 hasAuthorship W4288045131A5048622877 @default.
- W4288045131 hasAuthorship W4288045131A5087160785 @default.
- W4288045131 hasBestOaLocation W42880451311 @default.
- W4288045131 hasConcept C118552586 @default.
- W4288045131 hasConcept C126322002 @default.
- W4288045131 hasConcept C139719470 @default.
- W4288045131 hasConcept C15744967 @default.
- W4288045131 hasConcept C162324750 @default.
- W4288045131 hasConcept C2776867660 @default.
- W4288045131 hasConcept C2779177272 @default.
- W4288045131 hasConcept C2779631380 @default.
- W4288045131 hasConcept C2780051608 @default.
- W4288045131 hasConcept C2780600973 @default.
- W4288045131 hasConcept C2780733359 @default.
- W4288045131 hasConcept C2780795376 @default.
- W4288045131 hasConcept C558461103 @default.
- W4288045131 hasConcept C71924100 @default.
- W4288045131 hasConceptScore W4288045131C118552586 @default.
- W4288045131 hasConceptScore W4288045131C126322002 @default.
- W4288045131 hasConceptScore W4288045131C139719470 @default.
- W4288045131 hasConceptScore W4288045131C15744967 @default.
- W4288045131 hasConceptScore W4288045131C162324750 @default.
- W4288045131 hasConceptScore W4288045131C2776867660 @default.
- W4288045131 hasConceptScore W4288045131C2779177272 @default.
- W4288045131 hasConceptScore W4288045131C2779631380 @default.
- W4288045131 hasConceptScore W4288045131C2780051608 @default.
- W4288045131 hasConceptScore W4288045131C2780600973 @default.
- W4288045131 hasConceptScore W4288045131C2780733359 @default.
- W4288045131 hasConceptScore W4288045131C2780795376 @default.
- W4288045131 hasConceptScore W4288045131C558461103 @default.
- W4288045131 hasConceptScore W4288045131C71924100 @default.
- W4288045131 hasFunder F4320332161 @default.
- W4288045131 hasFunder F4320337346 @default.
- W4288045131 hasLocation W42880451311 @default.
- W4288045131 hasLocation W42880451312 @default.
- W4288045131 hasOpenAccess W4288045131 @default.
- W4288045131 hasPrimaryLocation W42880451311 @default.
- W4288045131 hasRelatedWork W2051093069 @default.
- W4288045131 hasRelatedWork W2099749043 @default.
- W4288045131 hasRelatedWork W2106636235 @default.
- W4288045131 hasRelatedWork W2402658701 @default.
- W4288045131 hasRelatedWork W2472214535 @default.
- W4288045131 hasRelatedWork W2557421272 @default.
- W4288045131 hasRelatedWork W2945361245 @default.
- W4288045131 hasRelatedWork W3213166294 @default.
- W4288045131 hasRelatedWork W4362733790 @default.
- W4288045131 hasRelatedWork W4380208228 @default.
- W4288045131 hasVolume "315" @default.
- W4288045131 isParatext "false" @default.
- W4288045131 isRetracted "false" @default.
- W4288045131 workType "article" @default.